Javier Hidalgo Tallón
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Indirect Endovenous Systemic Ozone for New Coronavirus Disease (COVID19) in Non-intubated Patients (NCT04359303) | Javier Hidalgo Tallón | 2020-07-01 |
Track Javier Hidalgo Tallón automatically
Every clearance here is in the API, with alerts when new ones post.